Variant report

Variant	esv2422407
Chromosome Location	chr6:31240954-31322934
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:666)
CpG islands
(count:2504)
Chromatin interactive
region (count:34)
LncRNA
region (count:15)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:666 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr6:31272445-31272772	K562	blood:	n/a	n/a
2	ATF2	chr6:31272379-31272838	GM12878	blood:	n/a	n/a
3	ATF2	chr6:31272219-31272895	GM12878	blood:	n/a	n/a
4	ATF2	chr6:31318632-31319385	GM12878	blood:	n/a	n/a
5	ATF2	chr6:31300411-31301086	GM12878	blood:	n/a	n/a
6	ATF2	chr6:31318444-31319386	GM12878	blood:	n/a	n/a
7	ATF2	chr6:31319512-31321668	GM12878	blood:	n/a	n/a
8	ATF2	chr6:31319422-31321748	GM12878	blood:	n/a	n/a
9	ATF2	chr6:31300449-31301004	GM12878	blood:	n/a	n/a
10	BACH1	chr6:31276089-31276266	H1-hESC	embryonic stem cell:	n/a	n/a
11	BATF	chr6:31300476-31300903	GM12878	blood:	n/a	n/a
12	BATF	chr6:31241012-31241391	GM12878	blood:	n/a	n/a
13	BATF	chr6:31300427-31300985	GM12878	blood:	n/a	n/a
14	BATF	chr6:31241031-31241428	GM12878	blood:	n/a	n/a
15	BCL11A	chr6:31241052-31241373	GM12878	blood:	n/a	n/a
16	BCL11A	chr6:31241100-31241317	GM12878	blood:	n/a	n/a
17	BCL11A	chr6:31318775-31319206	GM12878	blood:	n/a	n/a
18	BCL11A	chr6:31320393-31320678	GM12878	blood:	n/a	n/a
19	BCL11A	chr6:31319413-31321023	GM12878	blood:	n/a	n/a
20	BCL11A	chr6:31300656-31300925	GM12878	blood:	n/a	n/a
21	BCL3	chr6:31319812-31321116	GM12878	blood:	n/a	n/a
22	BCL3	chr6:31319415-31320898	GM12878	blood:	n/a	n/a
23	BCLAF1	chr6:31319409-31321119	GM12878	blood:	n/a	n/a
24	BCLAF1	chr6:31322541-31323765	GM12878	blood:	n/a	n/a
25	BCLAF1	chr6:31321125-31321669	GM12878	blood:	n/a	chr6:31321139-31321152 chr6:31321455-31321463
26	BCLAF1	chr6:31318701-31319362	GM12878	blood:	n/a	n/a
27	BCLAF1	chr6:31300404-31300834	GM12878	blood:	n/a	n/a
28	BCLAF1	chr6:31322776-31323862	GM12878	blood:	n/a	n/a
29	BCLAF1	chr6:31319416-31321907	GM12878	blood:	n/a	chr6:31321139-31321152 chr6:31321455-31321463
30	BCLAF1	chr6:31318925-31319357	GM12878	blood:	n/a	n/a
31	BCLAF1	chr6:31322218-31322709	GM12878	blood:	n/a	n/a
32	BHLHE40	chr6:31319623-31320237	GM12878	blood:	n/a	n/a
33	BHLHE40	chr6:31320567-31320928	GM12878	blood:	n/a	n/a
34	BHLHE40	chr6:31318412-31318711	GM12878	blood:	n/a	n/a
35	BRCA1	chr6:31319716-31319729	GM12878	blood:	n/a	n/a
36	CBX3	chr6:31272647-31272911	K562	blood:	n/a	n/a
37	CBX3	chr6:31304557-31305309	HCT-116	colon:	n/a	n/a
38	CBX3	chr6:31308020-31308398	HCT-116	colon:	n/a	n/a
39	CBX3	chr6:31296085-31296471	K562	blood:	n/a	n/a
40	CBX3	chr6:31308059-31308327	K562	blood:	n/a	n/a
41	CBX3	chr6:31304563-31305062	HCT-116	colon:	n/a	n/a
42	CBX3	chr6:31296167-31296435	K562	blood:	n/a	n/a
43	CBX3	chr6:31308066-31308395	K562	blood:	n/a	n/a
44	CBX3	chr6:31273672-31273874	K562	blood:	n/a	n/a
45	CBX3	chr6:31296053-31296562	HCT-116	colon:	n/a	n/a
46	CEBPB	chr6:31253886-31253955	K562	blood:	n/a	chr6:31253908-31253917
47	CEBPB	chr6:31298472-31298769	HepG2	liver:	n/a	chr6:31298602-31298613
48	CEBPB	chr6:31298538-31298651	K562	blood:	n/a	chr6:31298602-31298613
49	CEBPB	chr6:31298559-31298674	A549	lung:	n/a	chr6:31298602-31298613
50	CEBPB	chr6:31319547-31321170	GM12878	blood:	n/a	n/a

(count:2504 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:31275551-31275601	A549	lung:	n/a
2	chr6:31275767-31275817	HCF	heart:	n/a
3	chr6:31276088-31276138	ovcar-3	ovarian:	n/a
4	chr6:31275551-31275601	A549	lung:	n/a
5	chr6:31275767-31275817	HCF	heart:	n/a
6	chr6:31276088-31276138	ovcar-3	ovarian:	n/a
7	chr6:31276088-31276138	HRPEpiC	eye:	n/a
8	chr6:31272449-31272499	NHBE	bronchial:	n/a
9	chr6:31322298-31322348	K562	blood:	n/a
10	chr6:31242584-31242634	GM06990	blood:	n/a
11	chr6:31276434-31276484	AG04449	skin:	fetal
12	chr6:31276105-31276155	HRPEpiC	eye:	n/a
13	chr6:31322298-31322348	Hela-S3	cervix:	n/a
14	chr6:31275267-31275317	Hela-S3	cervix:	n/a
15	chr6:31276667-31276717	MCF-7	breast:	n/a
16	chr6:31322914-31322964	Hela-S3	cervix:	n/a
17	chr6:31322766-31322816	HPAEpiC	pulmonary alveolar:	n/a
18	chr6:31322914-31322964	CMK	blood:	n/a
19	chr6:31321433-31321483	HIPEpiC	eye:	n/a
20	chr6:31272449-31272499	ProgFib	skin:	n/a
21	chr6:31276667-31276717	SK-N-SH	brain:	n/a
22	chr6:31276212-31276262	H1-hESC	embryonic stem cell:	embryo
23	chr6:31322577-31322627	PrEC	prostate:	n/a
24	chr6:31276088-31276138	AG09309	skin:	n/a
25	chr6:31276212-31276262	HRCEpiC	kidney:	n/a
26	chr6:31276146-31276196	NHBE	bronchial:	n/a
27	chr6:31322766-31322816	GM12892	blood:	n/a
28	chr6:31275267-31275317	PANC-1	pancreas:	n/a
29	chr6:31276088-31276138	SKMC	muscle:	n/a
30	chr6:31275767-31275817	Hepatocyte	liver:	n/a
31	chr6:31322121-31322171	BJ	skin:	n/a
32	chr6:31276653-31276703	RPTEC	kidney:	n/a
33	chr6:31276437-31276487	HNPCEpiC	eye:	n/a
34	chr6:31276664-31276714	AG09309	skin:	n/a
35	chr6:31322914-31322964	A549	lung:	n/a
36	chr6:31322926-31322976	HCM	heart:	n/a
37	chr6:31272449-31272499	AG10803	skin:	n/a
38	chr6:31321433-31321483	HRCEpiC	kidney:	n/a
39	chr6:31275551-31275601	Caco-2	colon:	n/a
40	chr6:31275741-31275791	AG09319	gingival:	n/a
41	chr6:31322348-31322398	IMR90	lung:	fetal
42	chr6:31276105-31276155	HUVEC	blood vessel:	n/a
43	chr6:31276418-31276468	HCT-116	colon:	n/a
44	chr6:31322577-31322627	HepG2	liver:	n/a
45	chr6:31275718-31275768	HIPEpiC	eye:	n/a
46	chr6:31275148-31275198	RPTEC	kidney:	n/a
47	chr6:31250765-31250815	NHBE	bronchial:	n/a
48	chr6:31276437-31276487	NB4	blood:	n/a
49	chr6:31322926-31322976	HCT-116	colon:	n/a
50	chr6:31275267-31275317	HUVEC	blood vessel:	n/a

(count:34 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:31233619..31236964-chr6:31319655..31321766,4	MCF-7	breast:
2	chr6:31129596..31132185-chr6:31285768..31288675,2	MCF-7	breast:
3	chr6:31274576..31277552-chr6:31281409..31285159,3	MCF-7	breast:
4	chr6:31256122..31258941-chr6:31260246..31262615,2	MCF-7	breast:
5	chr6:31260319..31263250-chr6:31266330..31267976,2	K562	blood:
6	chr6:31260315..31262066-chr6:31270612..31272546,2	MCF-7	breast:
7	chr6:31251382..31252914-chr6:31343854..31345706,2	MCF-7	breast:
8	chr6:31273049..31275255-chr6:31283813..31285352,2	MCF-7	breast:
9	chr6:31274551..31276643-chr6:31277971..31279738,2	MCF-7	breast:
10	chr6:31272067..31274682-chr6:31275532..31277366,2	MCF-7	breast:
11	chr6:31283440..31285991-chr6:31367270..31369843,2	K562	blood:
12	chr6:31282655..31287685-chr6:31288202..31290762,5	K562	blood:
13	chr6:29910138..29911769-chr6:31239456..31240978,2	MCF-7	breast:
14	chr6:31260319..31263250-chr6:31266330..31267976,2	K562	blood:
15	chr6:31296846..31298783-chr6:31302678..31304651,2	K562	blood:
16	chr6:31279746..31282778-chr6:31284004..31286802,3	K562	blood:
17	chr6:31262379..31263887-chr6:31264452..31266692,2	MCF-7	breast:
18	chr6:31164078..31166363-chr6:31260745..31263696,2	K562	blood:
19	chr6:31282655..31287685-chr6:31288202..31290762,5	K562	blood:
20	chr6:31238404..31240559-chr6:31321762..31324439,3	MCF-7	breast:
21	chr6:31260192..31262611-chr6:31284045..31286889,2	K562	blood:
22	chr6:31260192..31262611-chr6:31284045..31286889,2	K562	blood:
23	chr6:31272998..31275186-chr6:31333057..31335314,2	K562	blood:
24	chr6:31296846..31298783-chr6:31302678..31304651,2	K562	blood:
25	chr6:31279746..31282778-chr6:31284004..31286802,3	K562	blood:
26	chr6:31232397..31234509-chr6:31319658..31321454,2	MCF-7	breast:
27	chr6:31312332..31314314-chr6:31315849..31318317,2	K562	blood:
28	chr6:31312332..31314314-chr6:31315849..31318317,2	K562	blood:
29	chr6:31274011..31276374-chr6:31277383..31280033,2	K562	blood:
30	chr6:31164078..31167331-chr6:31260118..31263696,3	K562	blood:
31	chr6:31262379..31263887-chr6:31264452..31266692,2	MCF-7	breast:
32	chr6:31251033..31253649-chr6:31335443..31337577,2	MCF-7	breast:
33	chr6:31260315..31262066-chr6:31270612..31272546,2	MCF-7	breast:
34	chr6:31273049..31275255-chr6:31283813..31285352,2	MCF-7	breast:

(count:15 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HLA-C-1	chr6:31261992-31262072	ENSG00000256166
2	lnc-HLA-C-2	chr6:31322256-31322583	NONHSAT108752
3	lnc-HLA-C-3	chr6:31249994-31250026	NONHSAT108749
4	lnc-HLA-C-4	chr6:31275592-31275824	NONHSAT108751
5	lnc-HLA-C-1	chr6:31261685-31261898	ENSG00000256166
6	lnc-HLA-C-4	chr6:31276254-31276326	NONHSAT108751
7	lnc-HLA-C-2	chr6:31321649-31322073	NONHSAT108753
8	lnc-HLA-C-2	chr6:31322410-31322853	NONHSAT108753
9	lnc-HLA-C-1	chr6:31269249-31269419	ENSG00000256166
10	lnc-HLA-C-3	chr6:31249491-31249789	NONHSAT108749
11	lnc-HLA-C-1	chr6:31262721-31262790	ENSG00000256166
12	lnc-HLA-C-2	chr6:31321649-31322073	NONHSAT108752
13	lnc-HLA-C-2	chr6:31322256-31322303	NONHSAT108753
14	lnc-HLA-C-2	chr6:31322256-31322303	NONHSAT108747
15	lnc-HLA-C-3	chr6:31253395-31253655	NONHSAT108749

No data

Variant related genes	Relation type
ENSG00000229836	TF binding region
RPL3P2	TF binding region
HLA-C	TF binding region
USP8P1	TF binding region
ENSG00000271581	TF binding region
HLA-B	TF binding region
WASF5P	TF binding region
ENSG00000256166	TF binding region
ENSG00000229836	CpG island
RPL3P2	CpG island
HLA-C	CpG island
USP8P1	CpG island
ENSG00000271581	CpG island
HLA-B	CpG island
WASF5P	CpG island
ENSG00000256166	CpG island
ENSG00000272501	chromatin interactions
ENSG00000230994	chromatin interactions
ENSG00000206503	chromatin interactions
ENSG00000206337	chromatin interactions
ENSG00000228432	chromatin interactions
ENSG00000229836	chromatin interactions
ENSG00000227766	chromatin interactions
ENSG00000204525	chromatin interactions
ENSG00000231402	chromatin interactions
ENSG00000206344	chromatin interactions

Extended variants
information (count: 3422 )
Associated
traits (count: 126 )

Variant overlapped rSNPs/rCNVs (count:3422 , 50 per page) page: 1 2 3 4 5 6 7 ... 69

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7773175	chr6:31240959-31240960	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs7759127	chr6:31240988-31240989	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs375679493	chr6:31240993-31240994	Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs13191099	chr6:31241002-31241003	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs116468243	chr6:31241031-31241032	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
6	rs139073773	chr6:31241035-31241036	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
7	rs142978245	chr6:31241046-31241047	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
8	rs552159963	chr6:31241056-31241057	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs536373059	chr6:31241060-31241061	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs371992891	chr6:31241063-31241064	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs564023430	chr6:31241069-31241070	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs35976302	chr6:31241077-31241078	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs2523599	chr6:31241092-31241093	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs13191343	chr6:31241109-31241110	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	disease
15	rs550469785	chr6:31241120-31241121	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs13207315	chr6:31241127-31241128	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs200939896	chr6:31241145-31241146	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs150036304	chr6:31241148-31241149	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs201913856	chr6:31241150-31241151	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs558032722	chr6:31241178-31241179	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs6900444	chr6:31241182-31241183	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
22	rs572255631	chr6:31241198-31241199	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs6900458	chr6:31241207-31241208	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs58019823	chr6:31241215-31241216	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs185029973	chr6:31241218-31241219	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs6900474	chr6:31241236-31241237	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs114183633	chr6:31241241-31241242	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs572250590	chr6:31241258-31241259	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs377276311	chr6:31241259-31241260	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs2524088	chr6:31241260-31241261	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs6900323	chr6:31241270-31241271	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
32	rs189456290	chr6:31241279-31241280	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs181731481	chr6:31241289-31241290	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs2524087	chr6:31241294-31241295	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs2524086	chr6:31241311-31241312	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs571836544	chr6:31241351-31241352	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs34090104	chr6:31241353-31241354	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs6923313	chr6:31241370-31241371	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
39	rs150356282	chr6:31241373-31241374	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs116713535	chr6:31241495-31241496	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs2844621	chr6:31241537-31241538	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
42	rs115813605	chr6:31241585-31241586	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs34255701	chr6:31241600-31241601	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs2524084	chr6:31241639-31241640	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
45	rs545565121	chr6:31241642-31241643	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs28729867	chr6:31241643-31241644	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs376167268	chr6:31241654-31241655	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs2853949	chr6:31241664-31241665	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs370204651	chr6:31241668-31241669	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs12525626	chr6:31241700-31241701	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:126)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Melanoma	17363583	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Breast cancer	21364760	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glioma	20126413	CNVD

Chromatin state (count:608 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:31238400-31241000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
2	chr6:31238400-31241000	Active TSS	Pancreatic Islets	Pancreatic Islet
3	chr6:31238600-31241000	Active TSS	Right Atrium	heart
4	chr6:31239000-31241000	Active TSS	Primary T killer naive cells fromperipheralblood	blood
5	chr6:31239000-31241000	Active TSS	Primary T killer memory cells from peripheral blood	blood
6	chr6:31239000-31241000	Active TSS	Duodenum Mucosa	Duodenum
7	chr6:31239000-31241200	Active TSS	Primary T helper naive cells from peripheral blood	blood
8	chr6:31239000-31241200	Active TSS	Rectal Mucosa Donor 29	rectum
9	chr6:31239000-31241200	Active TSS	Rectal Smooth Muscle	rectum
10	chr6:31239200-31241200	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood
11	chr6:31239800-31241800	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
12	chr6:31240000-31241000	Flanking Active TSS	Primary B cells from peripheral blood	blood
13	chr6:31240000-31241000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr6:31240200-31241000	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
15	chr6:31240200-31241000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
16	chr6:31240200-31241000	Flanking Active TSS	Primary T cells from cord blood	blood
17	chr6:31240200-31241000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
18	chr6:31240200-31241200	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
19	chr6:31240200-31241200	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
20	chr6:31240200-31241600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr6:31240200-31241600	Flanking Active TSS	GM12878-XiMat	blood
22	chr6:31240400-31241000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
23	chr6:31240400-31241000	Flanking Active TSS	Primary B cells from cord blood	blood
24	chr6:31240400-31241000	Flanking Active TSS	Brain Substantia Nigra	brain
25	chr6:31240400-31241000	Flanking Bivalent TSS/Enh	HepG2	liver
26	chr6:31240400-31241600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
27	chr6:31240600-31241000	Enhancers	Brain Germinal Matrix	brain
28	chr6:31240600-31241000	Active TSS	Brain Inferior Temporal Lobe	brain
29	chr6:31240600-31241000	Enhancers	NHEK	skin
30	chr6:31240600-31241200	Enhancers	Primary hematopoietic stem cells short term culture	blood
31	chr6:31240600-31241200	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
32	chr6:31240600-31241200	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
33	chr6:31240600-31241200	Enhancers	Fetal Thymus	thymus
34	chr6:31240600-31241400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr6:31240800-31241000	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
36	chr6:31240800-31241000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
37	chr6:31240800-31241000	Enhancers	Primary hematopoietic stem cells	blood
38	chr6:31240800-31241000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
39	chr6:31240800-31241000	Flanking Active TSS	Adipose Nuclei	Adipose
40	chr6:31240800-31241000	Flanking Active TSS	Brain Anterior Caudate	brain
41	chr6:31240800-31241000	Enhancers	Brain Hippocampus Middle	brain
42	chr6:31240800-31241000	Enhancers	Colon Smooth Muscle	Colon
43	chr6:31240800-31241000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
44	chr6:31240800-31241000	Active TSS	Stomach Smooth Muscle	stomach
45	chr6:31240800-31241000	Enhancers	Dnd41	blood
46	chr6:31240800-31241000	Enhancers	Hela-S3	cervix
47	chr6:31240800-31241200	Enhancers	Breast Myoepithelial Primary Cells	Breast
48	chr6:31240800-31241200	Flanking Active TSS	Primary T cells fromperipheralblood	blood
49	chr6:31240800-31241400	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
50	chr6:31240800-31241800	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links